University of Otago
43
6
7
27
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.7%
2 terminated/withdrawn out of 43 trials
93.1%
+6.6% vs industry average
9%
4 trials in Phase 3/4
4%
1 of 27 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (43)
DIFFIR - Geriatric Distal Femur Fixation Versus Replacement
Role: collaborator
Vitamin C 4 Care Homes
Role: collaborator
Evaluation and Demonstration of New Tuberculosis Diagnostics for Indonesia
Role: collaborator
Brain Network Stimulation for Chronic Low Back Pain.
Role: lead
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
Role: collaborator
Eating Disorders Genetics Initiative 2
Role: collaborator
PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE
Role: collaborator
Occupational Performance Coaching With Parents of Young Children With Developmental Disability
Role: collaborator
Psilocybin-assisted Interpersonal Therapy for Depression
Role: lead
oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder
Role: lead
Virtual Reality for Cognitive Impairment in Hemodialysis
Role: collaborator
The ENERGYCO Study
Role: collaborator
oVRcome Self-guided Virtual Reality for Specific Phobias
Role: lead
Feasibility Study of a Group Intervention for Youth Wellbeing
Role: lead
Understanding Neurocognitive Impairment After Trauma Exposure
Role: lead
Sustainable Intervention of Supplementation to Improve Kid's Growth Study
Role: collaborator
Examine the Psychosocial Impacts of COVID-19 Pandemic.
Role: lead
Sustained Meat and Alternative Intake (PRotEin DIet SatisfacTION Trial 4) (PREDITION)
Role: collaborator
Increasing Notifications of Tuberculosis From Private Practitioners
Role: collaborator
Brain Substrate Switch to Ketones and Lactate
Role: collaborator